Answers are grounded in this paper and cite their sources.
Cancer cells undergo extensive metabolic reprogramming and can become dependent on glutamine to replenish the tricarboxylic acid cycle when glucose-derived carbon is diverted to lactate production, yet the transcriptional programs coordinating this response remain incompletely defined. We previously identified estrogen-related receptor gamma (ESRRG) as a driver of hypoxic adaptation in retinoblastoma (Rb), and here we show that ESRRG also regulates glutamine-responsive metabolism. ESRRG knockdown reduced transcriptional programs associated with glycolysis and glutamine utilization, while pharmacological inhibition with GSK5182 attenuated glutamine-dependent viability and survival. Conversely, ESRRG overexpression increased sensitivity to glutamine withdrawal in mesenchymal stem cells. Mechanistically, glutamine enhanced basal and maximal respiration, spare respiratory capacity, and ATP-linked respiration in Rb cells, whereas these responses were attenuated by GSK5182. Targeted LC-MS/MS profiling further showed reduced glutamine-responsive accumulation of intracellular glutamine, glutamate, α-ketoglutarate, and downstream TCA-associated metabolites following ESRRG inhibition. These findings identify ESRRG as a regulator of glutamine dependence and mitochondrial metabolic flexibility in Rb and nominate ESRRG-associated glutamine utilization as a potential metabolic vulnerability.
No takes yet. Share an insight, caveat, or question.
McLaughlin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: